Apollo Hospitals Bangalore launches “Robotic Joint Replacement Program”

Bangalore: Apollo Hospitals, Bangalore, has launched its first-of-a-kind knee replacement program, offering specialized partial and total knee replacement care with the use of advanced robotic technology. This program is coming handy in new normal caused by COVID.

The Robotic system has an advanced computed program that relays precise information about the knee with 3D mapping. The use of next generation robotics with smaller incision will result in less pain and lesser blood loss. Precision in bone cutting and better position of implant with alignment gives a near normal knee motion for both total and partial knee replacement.

The program which comes as a package designed for the new normal due to the COVID pandemic, comprises of home diagnostic tests / assessments, Apollo 24*7 app consultations, and post-surgical home care made available for the patients.

Dr.Pratap C Reddy, Chairman, Apollo Hospitals Group said, “Osteoarthritis is a rising health concern in India, with a prevalence rate between 22 – 39%. To overcome pain and limitations in mobility of such patients, Joint Replacement is the solution. The outcome of surgeries can be improved by leveraging technology. Today, robotic technology has come a long way, helping perform some of the most complicated surgeries with precision, and Apollo Hospitals has always been at the forefront of using technology in healthcare”.

Dr.Sangita Reddy, Joint Managing Director, Apollo Hospitals Group said, “Our vision has always been to bring the most advanced medical technology to India to benefit our patients. We are continuing on this path with the launch of the knee replacement program, assisted by robotic technology. At Apollo Hospitals, the patient is at the center of all our efforts in providing accessible and affordable world-class treatment, and the introduction of the NAVIO surgical system is in furtherance of this objective”.

Dr. Sanjay Pai, Sr Consultant, Orthopaedic Surgeon, Apollo Specialty Hospitals commented, “Today, we need to accept the reality that COVID-19 is here to stay, hence we have developed the robotic assisted total and partial knee replacement programme. The NAVIO surgical system is highly reliable and used in over 500centers worldwide. One of the major advantages of using robotic technology for total or partial knee replacement surgery is that smaller incisions imply lesser pain and also quick recovery which is definitely the need of the hour in Ortho care. The idea here is to ensure that the patients recover quickly and return to normalcy. Recovery is rapid, with lesser hospitalization, faster mobilization and rehabilitation. Our team of trained nursing professionals will ensure complete care and closed monitoring in the comfort of the patient’s home.”

Mr. Davison PK, Chief Executive Officer, Apollo Hospitals Karnataka region commented, “The comprehensive knee replacement program we have designed will now be accessible to patients, especially at times where most of them hesitate to come to the hospital, given the fear of COVID-19. At Apollo, while ensuring absolute safety measures for our patients, we also want to provide care at their comfort.”

Related Posts

Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

Association of Indian Medical Device Industry (AiMeD) sends SOS to Union Minister Piyush Goel New Delhi: The war tremors have started shaking the domestic medical device industry perched on the…

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Dr D S Rana, Chairman, Sir Ganga Ram Trust Society was Cynosure of all Eyes New Delhi: Inaugural Conference of Critical Nephrology Society of India CNSICON 26 under the aegis…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework